News und Analysen
EQS-News: M1 Kliniken AG announces figures for Q3 2022: Group continues the expansion course with development of a new country market
EQS-News: M1 Kliniken AG announces figures for Q3 2022: Group continues the expansion course with development of a new country market
EQS-News: Eckert & Ziegler: Nine-Month Figures Show Strong Sales Growth
EQS-News: Eckert & Ziegler: Nine-Month Figures Show Strong Sales Growth
EQS-News: MediClin AG: Group sales and Group operating result above previous year − stable capacity utilization, energy costs weigh on result
EQS-News: MediClin AG: Group sales and Group operating result above previous year − stable capacity utilization, energy costs weigh on result
EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
EQS-News: MediClin AG: Disclosure of Significant Transactions with Related Parties pursuant to Section 111c of the German Stock Corporation Act (AktG)
EQS-News: MediClin AG: Disclosure of Significant Transactions with Related Parties pursuant to Section 111c of the German Stock Corporation Act (AktG)
EQS-Adhoc: MEDICLIN reaches agreement regarding early renewal of lease agreements for 20 clinic locations and settlement of lease dispute with (former) shareholders
EQS-Adhoc: MEDICLIN reaches agreement regarding early renewal of lease agreements for 20 clinic locations and settlement of lease dispute with (former) shareholders
EQS-News: Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement
EQS-News: Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement
EQS-News: Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility
EQS-News: Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility
EQS-News: MediClin AG: MEDICLIN plans to close the Schlüsselbad Klinik in Bad Peterstal by the end of 2022, subject to the outcome of the consultations with the works council
EQS-News: MediClin AG: MEDICLIN plans to close the Schlüsselbad Klinik in Bad Peterstal by the end of 2022, subject to the outcome of the consultations with the works council
DGAP-Adhoc: MeVis Medical Solutions AG: Raising forecast for the current fiscal year
DGAP-Adhoc: MeVis Medical Solutions AG: Raising forecast for the current fiscal year
DGAP-News: Vita 34 records moderate upward trend in the second quarter
DGAP-News: Vita 34 records moderate upward trend in the second quarter
DGAP-Adhoc: Vita 34 lowers sales and earnings guidance due to IFRS 15 effect and accelerated restructuring measures
DGAP-Adhoc: Vita 34 lowers sales and earnings guidance due to IFRS 15 effect and accelerated restructuring measures
DGAP-News: M1 Kliniken AG announces financials for H1-2022: positive business development despite cooling of general consumer climate
DGAP-News: M1 Kliniken AG announces financials for H1-2022: positive business development despite cooling of general consumer climate
DGAP-News: Eckert & Ziegler with Successful First Half of 2022
DGAP-News: Eckert & Ziegler with Successful First Half of 2022
DGAP-News: Eckert & Ziegler Affiliate to Receive Multi-Million Euro Grant from the European Defense Fund for Development of Medical Countermeasures
DGAP-News: Eckert & Ziegler Affiliate to Receive Multi-Million Euro Grant from the European Defense Fund for Development of Medical Countermeasures
DGAP-News: MediClin AG: Consolidated sales for the first half of 2022 up 10% on the previous pandemic figure – no change in forecast
DGAP-News: MediClin AG: Consolidated sales for the first half of 2022 up 10% on the previous pandemic figure – no change in forecast
DGAP-Adhoc: Eckert & Ziegler: Strong Growth in Revenues and Earnings in 2nd Quarter
DGAP-Adhoc: Eckert & Ziegler: Strong Growth in Revenues and Earnings in 2nd Quarter
DGAP-News: Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Development
DGAP-News: Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Development
DGAP-News: Eckert & Ziegler and PRECIRIX Sign Agreement on Priority Supply of the Therapeutic Radioisotope Actinium-225 (Ac-225)
DGAP-News: Eckert & Ziegler and PRECIRIX Sign Agreement on Priority Supply of the Therapeutic Radioisotope Actinium-225 (Ac-225)
DGAP-News: Eckert & Ziegler Becomes Contract Manufacturer for Clinical Development Candidates Based on Lutetium-177 and Actinium-225
DGAP-News: Eckert & Ziegler Becomes Contract Manufacturer for Clinical Development Candidates Based on Lutetium-177 and Actinium-225
DGAP-Adhoc: Eckert & Ziegler Lowers 2022 Profit Guidance to 27 mm EUR
DGAP-Adhoc: Eckert & Ziegler Lowers 2022 Profit Guidance to 27 mm EUR
DGAP-News: Vita 34 introduces new Chief Financial Officer at the Annual General Meeting
DGAP-News: Vita 34 introduces new Chief Financial Officer at the Annual General Meeting
DGAP-News: Vita 34 sees first signs of stabilization in core business after war-related weaker first quarter
DGAP-News: Vita 34 sees first signs of stabilization in core business after war-related weaker first quarter
DGAP-News: MeVis Medical Solutions AG: MeVis publishes figures for the first half of fiscal year 2021/2022
DGAP-News: MeVis Medical Solutions AG: MeVis publishes figures for the first half of fiscal year 2021/2022
DGAP-News: M1 Kliniken AG announces financials for Q1-2022: further growth of Beauty segment; ongoing optimisation of Trade segment
DGAP-News: M1 Kliniken AG announces financials for Q1-2022: further growth of Beauty segment; ongoing optimisation of Trade segment